Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs (NCT07222995)

🧪 Interventions in This Study

• Precision Prevention Booklet (BEHAVIORAL)
• Standard Prevention Booklet (BEHAVIORAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Moffitt Cancer Center — Tampa, Florida
• Memorial Sloan Kettering Cancer Center — New York, New York

📞 Contact the Study Coordinator

Phone: (813) 745-6813

Email: Rania.Abdulla@moffitt.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Skin Cancer

• Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers — Madison, Wisconsin
• In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin — Basking Ridge, New Jersey
• A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers. — Brooklyn, New York
• Undergraduate Skin Cancer Prevention Trial — Salt Lake City, Utah
• A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients — Pittsburgh, Pennsylvania

Explore by condition: All Skin Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.